Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
Borderline ovarian tumors (BOT) are uncommon but not rare epithelial ovarian neoplasms, intermediate between benign and malignant categories. Since BOT were first identified >40 years ago, they have inspired controversies disproportionate to their incidence. This review discusses diagnostic criteria for the histologic subtypes of BOT, highlighting areas of diagnostic challenges, ongoing controversies, and changes in terminology implemented by the recent 2014 WHO Classification of Tumours of the Female Genital Organs. Emerging knowledge supports the notion that subtypes of borderline ovarian tumors comprise distinct biologic, pathogenetic, and molecular entities, precluding a single unifying concept for BOT. Serous borderline tumors (SBT) share molecular and genetic alterations with low-grade serous carcinomas and can present at higher stages with peritoneal implants and/or lymph node involvement, which validates their borderline malignant potential. All other (non-serous) subtypes of BOT commonly present at stage I confined to the ovary(ies) and are associated with overall survival approaching that of the general population. An important change in the WHO 2014 classification is the new terminology of non-invasive implants associated with SBT, as any invasive foci (previously called "invasive implants") are now in line with their biological behavior considered peritoneal low-grade serous carcinoma (LGSC). The controversy regarding the terminology of non-serous borderline tumors, called by some pathologists "atypical proliferative tumor" in view of their largely benign behavior, has not been resolved. The concepts of intraepithelial carcinoma and microinvasion may evolve in further studies, as their presence appears to have no prognostic impact and is subject to considerable inter-observer variability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
Pathology and Genetics of Tumours of the Breast and Female Genital Organs
Tavassoli, F. A., & Devilee, P. (2003) · International Agency for Research on Cancer eBooks · Cited by 2,800
WHO classification of tumours of female reproductive organs
Kurman, R. J., Carcangiu, M. L., Herrington, C. S., & Young, R. H. (2014) · International Agency for Research on Cancer eBooks · Cited by 1,966
Giudice, L. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1000274 · Cited by 1,924
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Kurman, R. J., & Shih, I.-M. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181cf3d79 · Cited by 1,846
Shih, I.-M., & Kurman, R. J. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63708-x · Cited by 1,206
Mutations in BRAF and KRAS Characterize the Development of Low-Grade Ovarian Serous Carcinoma
Singer, G., Oldt, R., Cohen, Y., Wang, B. G., Sidransky, D., Kurman, R. J., & Shih, I.-M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.6.484 · Cited by 854
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Köbel, M., Kalloger, S. E., Boyd, N., McKinney, S., Mehl, E., Palmer, C., Leung, S., Bowen, N. J., Ionescu, D. N., Rajput, A., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050232 · Cited by 814
Grading Ovarian Serous Carcinoma Using a Two-Tier System
Malpica, A., Deavers, M. T., Lu, K., Bodurka, D. C., Atkinson, E. N., Gershenson, D. M., & Silva, E. G. (2004) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200404000-00009 · Cited by 670
Histological Typing of Ovarian Tumours
Scully, R. E. (1999) · Springer eBooks · doi:10.1007/978-3-642-58564-7 · Cited by 654
Kurman, R. J., & Shih, I.-M. (2008) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e318161e4f5 · Cited by 460
A Comprehensive Analysis of PAX8 Expression in Human Epithelial Tumors
Laury, A. R., Perets, R., Piao, H., Krane, J. F., Barletta, J. A., French, C., Chirieac, L. R., Lis, R., Loda, M., Hornick, J. L., et al. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318216c112 · Cited by 460
Seidman, J. D., & Kurman, R. J. (2000) · Human Pathology · doi:10.1053/hp.2000.8048 · Cited by 410
Singer, G., Stöhr, R., Cope, L., Dehari, R., Hartmann, A., Cao, D.-F., Wang, T.-L., Kurman, R. J., & Shih, I.-M. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000146025.91953.8d · Cited by 408
Lee, K. R. C. K., & Scully, R. E. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200011000-00001 · Cited by 343
Longacre, T. A., McKenney, J. K., Tazelaar, H. D., Kempson, R. L., & Hendrickson, M. R. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000164030.82810.db · Cited by 323
Clement, P. B. (2007) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e3180ca7d7b · Cited by 320
Burks, R. T., Sherman, M. E., & Kurman, R. J. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199611000-00003 · Cited by 314
Clement, P. B. (1990) · PubMed · Cited by 305
Lee, K. R., & Young, R. H. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200303000-00001 · Cited by 293
Seidman, J. D., & Kurman, R. J. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199611000-00004 · Cited by 290
Classification and Staging of Malignant Tumours in the Female Pelvis
(1971) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.3109/00016347109157278 · Cited by 285
Serous Borderline Tumors of the Ovary
Prat, J., & Nictolis, M. D. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200209000-00002 · Cited by 283
Studies on Bilirubin in Amniotic Fluid: With Special Reference to Liver Function Tests
Ojala, A. (1971) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.3109/00016347109157182 · Cited by 271
Riopel, M. A., Ronnett, B. M., & Kurman, R. J. (1999) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199906000-00001 · Cited by 258
du Bois, A., Ewald-Riegler, N., de Gregorio, N., Reuss, A., Mahner, S., Fotopoulou, C., Kommoss, F., Schmalfeldt, B., Hilpert, F., Fehm, T., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.01.035 · Cited by 252
Self-citationMucinous tumors of the ovary: a review.
Hart, W. R. (2005) · PubMed · Cited by 246
Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy.
Mok, S. C., Bell, D. A., KNAPP, R. C., Fishbaugh, P. M., Welch, W. R., Muto, M. G., Berkowitz, R. S., & Tsao, S. (1993) · PubMed · Cited by 237
PAX8 Reliably Distinguishes Ovarian Serous Tumors From Malignant Mesothelioma
Laury, A. R., Hornick, J. L., Perets, R., Krane, J. F., Corson, J., Drapkin, R., & Hirsch, M. S. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181da7687 · Cited by 230
Rodríguez, I. M., & Prat, J. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200202000-00001 · Cited by 218
Meinhold-Heerlein, I., Bauerschlag, D., Hilpert, F., Dimitrov, P., Sapinoso, L. M., Orlowska-Volk, M., Bauknecht, T., Park, T.-W., Jonat, W., Jacobsen, A., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208298 · Cited by 205
Eichhorn, J. H., Bell, D. A., Young, R. H., & Scully, R. E. (1999) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199904000-00004 · Cited by 204
Ovarian serous borderline tumors with invasive peritoneal implants
Gershenson, D. M., Silva, E. G., Levy, L., Burke, T. W., Wolf, J. K., & Tornos, C. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980315)82:6<1096::aid-cncr13>3.0.co;2-1 · Cited by 203
Jiang, Z., Fanger, G. R., Woda, B. A., Banner, B. F., Algate, P., Dresser, K., Xu, J., & Chu, P. G. (2003) · Human Pathology · doi:10.1016/s0046-8177(03)00268-5 · Cited by 198
Anglesio, M. S., Kommoss, S., Tolcher, M. C., Clarke, B., Galletta, L., Porter, H., Damaraju, S., Fereday, S., Winterhoff, B. J., Kalloger, S. E., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4088 · Cited by 198
Ji, H., Isacson, C., Seidman, J. D., Kurman, R. J., & Ronnett, B. M. (2002) · International Journal of Gynecological Pathology · doi:10.1097/00004347-200210000-00009 · Cited by 195
Management of Borderline Ovarian Neoplasms
Cadron, I., Leunen, K., Van Gorp, T., Amant, F., Neven, P., & Vergote, I. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.8076 · Cited by 195
Spectrum of Mutation and Frequency of Allelic Deletion of the p53 Gene in Ovarian Cancer
Kohler, M. F., Marks, J. R., Wiseman, R. W., Jacobs, I. J., Davidoff, A. M., Clarke-Pearson, D. L., Soper, J. T., Bast, R. C., & Berchuck, A. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.18.1513 · Cited by 184
Sherman, M. E., Mink, P. J., Curtis, R., Cote, T. R., Brooks, S., Hartge, P., & Devesa, S. (2004) · Cancer · doi:10.1002/cncr.20080 · Cited by 179
Endometriosis and Ovarian Cancer: A Review of Clinical, Pathologic, and Molecular Aspects
Wei, J.-J., William, J., & Bulun, S. (2011) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31821f4b85 · Cited by 174
Mackenzie, R., Kommoss, S., Winterhoff, B. J. N., Kipp, B. R., García, J. J., Voss, J. S., Halling, K. C., Karnezis, A. N., Senz, J., Yang, W., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1421-8 · Cited by 172
Seidman, J. D., & Khedmati, F. (2008) · Archives of Pathology & Laboratory Medicine · doi:10.5858/132.11.1753 · Cited by 168
Seidman, J. D., Soslow, R. A., VANG, R. S., Berman, J. J., Stoler, M. H., Sherman, M. E., Oliva, E., Kajdacsy‐Balla, A., Berman, D. M., & Copeland, L. J. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.03.004 · Cited by 157
Prognostic factors for patients with advanced stage serous borderline tumours of the ovary
Morice, P., Camatte, S., Rey, A., Atallah, D. M., Lhommé, C., Pautier, P., Pomel, C., Coté, J.-F., Haie‐Méder, C., Morice, P., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg173 · Cited by 134
Pathogenesis and the Role of ARID1A Mutation in Endometriosis-related Ovarian Neoplasms
Maeda, D., & Shih, I. (2012) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e31827bc24d · Cited by 131
Cadherin-17 is a useful diagnostic marker for adenocarcinomas of the digestive system
Su, M.-C., Yuan, R., Lin, C., et al. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.107 · Cited by 129
Deavers, M. T., Gershenson, D. M., Tortolero‐Luna, G., Malpica, A. L., Lu, K. H., & Silva, E. G. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200209000-00003 · Cited by 126
The mTOR/AKT Inhibitor Temsirolimus Prevents Deep Infiltrating Endometriosis in Mice
Leconte, M., Nicco, C., Ngô, C., Chéreau, C., Chouzenoux, S., Marut, W., Guibourdenche, J., Arkwright, S., Weill, B. J., Chapron, C., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.04.020 · Cited by 123
Cuatrecasas, M., Catasús, L., Palacios, J., & Prat, J. (2009) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318188b84c · Cited by 120
Bell, K. A., & Kurman, R. J. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200011000-00002 · Cited by 118
The Fallopian Tube-Peritoneal Junction
Seidman, J. D., Yemelyanova, A. V., Zaino, R. J., et al. (2010) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e3181f29d2a · Cited by 106
McKenney, J. K., Balzer, B. L., & Longacre, T. A. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213299.11649.fa · Cited by 105
Yamamoto, S., Tsuda, H., Takano, M., Tamai, S., & Matsubara, O. (2011) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-011-1169-8 · Cited by 102
Dodson, M. K., Hartmann, L. C., Cliby, W. A., Delacey, K., Keeney, G. L., Ritland, S., Su, J. Q., Podratz, K. C., & Jenkins, R. B. (1993) · PubMed · Cited by 101
VANG, R. S., Gown, A. M., Barry, T. S., Wheeler, D. T., & Ronnett, B. M. (2005) · International Journal of Gynecological Pathology · doi:10.1097/01.pgp.0000177125.31046.fd · Cited by 100
Samartzis, E. P., Samartzis, N., Noske, A., Fedier, A., Caduff, R. F., Dedes, K. J., Fink, D. A., & Imesch, P. (2012) · Modern Pathology · doi:10.1038/modpathol.2011.217 · Cited by 99
VANG, R. S., Gown, A. M., Farinola, M. A., Barry, T. S., Wheeler, D. T., Yemelyanova, A. V., Seidman, J. D., Judson, K., & Ronnett, B. M. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213369.71676.25 · Cited by 96
A polymorphism in a let‐7 microRNA binding site of KRAS in women with endometriosis
Grechukhina, O., Petracco, R., Popkhadze, S., Massasa, E., Paranjape, T., Chan, E., Flores, I., Weidhaas, J. B., & Taylor, H. S. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100200 · Cited by 96
KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay
Auner, V., Kriegshäuser, G., Castillo‐Tong, D. C., Horvat, R., Reinthaller, A., Mustea, A., & Zeillinger, R. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-111 · Cited by 93
Quantification of ER/PR expression in ovarian low-grade serous carcinoma
Escobar, J., Klimowicz, A. C., Dean, M. L., Chu, P., Nation, J. G., Nelson, G. S., Ghatage, P., Kalloger, S. E., & Köbel, M. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.10.013 · Cited by 87
Wu, C. H., Mao, T., VANG, R. S., Ayhan, A., Wang, T., Kurman, R. J., & Shih, I. (2012) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31823f8482 · Cited by 86
Seromucinous Tumors of the Ovary. What’s in a Name?
Kurman, R. J., & Shih, I. (2015) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000000266 · Cited by 79
Uzan, C., Nikpayam, M., Ribassin-Majed, L., Gouy, S., Bendifallah, S., Cortez, A., Rey, A., Morice, P., Daraï, É., & Morice, P. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu139 · Cited by 73
May, T., Virtanen, C., Sharma, M., Milea, A. L., Begley, H., Rosen, B. P., Murphy, K. J., Brown, T. J., & Shaw, P. A. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.01.006 · Cited by 72
Micropapillary pattern in serous borderline ovarian tumors: Does it matter?
Park, J., Kim, D., Kim, J.-H., Kim, Y., Kim, K.-R., Kim, Y., & Nam, J. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.08.008 · Cited by 62
The Utility of Immunohistochemistry in the Differential Diagnosis of Gynecologic Disorders
Kaspar, H. G., & Crum, C. P. (2014) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2014-0057-ra · Cited by 58
Stewart, C. J. R., Leung, Y. C., Walsh, M. D., Walters, R., Young, J. P., & Buchanan, D. D. (2012) · Human Pathology · doi:10.1016/j.humpath.2011.10.009 · Cited by 57
WT1 Expression in the Female Genital Tract
Bárcena, C., & Oliva, E. (2011) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e318234aaed · Cited by 55
Kim, K.-R., Choi, J., Hwang, J., Baik, Y., Shim, J. Y., Kim, Y. M., & Robboy, S. J. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03673.x · Cited by 53
Staebler, A., Heselmeyer‐Haddad, K., Bell, K. A., Riopel, M. A., Perlman, E. J., Ried, T., & Kurman, R. J. (2002) · Human Pathology · doi:10.1053/hupa.2002.30212 · Cited by 52
Yasunaga, M., Ohishi, Y., Oda, Y., Misumi, M., Iwasa, A., Kurihara, S., Nishimura, I., Okuma, E., Kobayashi, H., Wake, N., et al. (2009) · Human Pathology · doi:10.1016/j.humpath.2008.12.006 · Cited by 44
Körner, M., Burckhardt, E., & Mazzucchelli, L. (2006) · Modern Pathology · doi:10.1038/modpathol.3800699 · Cited by 36
Histopathologic features of ovarian borderline tumors are not predictive of clinical outcome
Avril, S., Hahn, E., Specht, K., Hauptmann, S., Höß, C., Kiechle, M. B., Höfler, H., & Schmalfeldt, B. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.08.027 · Cited by 30
Self-citationSilva, E. G., Deavers, M. T., & Malpica, A. L. (2010) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e3181e31f74 · Cited by 23
Langendonckt, A. V., Luyckx, M., Gonzalez, M.-D., Defrère, S., Donnez, J., & Squifflet, J. P. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.01.003 · Cited by 16
Cited by
Colombo, N., Sessa, C., du Bois, A., Ledermann, J., McCluggage, W. G., McNeish, I., Morice, P., Pignata, S., Ray-Coquard, I., Vergote, I., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz062 · Cited by 1,197
Colombo, N., Sessa, C., Bois, A. D., Ledermann, J., McCluggage, W., McNeish, I., Morice, P., Pignata, S., Ray-Coquard, I., Vergote, I., et al. (2019) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2019-000308 · Cited by 407
Metadata
- Authors
- Hauptmann, S., Friedrich, K., Redline, R., & Avril, S.
- Venue
- Virchows Archiv
- Published
- 2016-12-27
- Volume
- 470
- Issue
- 2
- Pages
- 125-142
- ISSN
- 0945-6317 (ISSN-L)
- 1432-2307
- OpenAlex
- W2565033598
- Cited by
- 270
- References
- 75
- FWCI
- 17.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.